Ivonescimab significantly improves overall survival versus pembrolizumab in advanced lung cancer

Greek Astrophysicist Calls for European Space Autonomy

Trial supports MRI surveillance over preventive brain radiation in small-cell lung cancer

Combination therapy does not meet primary endpoints in first-line PD-L1-high metastatic non-small cell lung cancer

Tam-Peli extends survival by nearly four months in relapsed small-cell lung cancer